Salt-sensitive hypertension develops after transient induction of ANG II-dependent hypertension in Cyp1a1-Ren2 transgenic rats

American Journal of Physiology - Renal Physiology

Volumn 288, Issue 4 57-4, 2005, Pages

  Howard, Laura L ^a   Patterson, Matthew E ^a   Mullins, John J ^b   Mitchell, Kenneth D ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Kidney; Renal hemodynamics; Sodium excretion; Superoxide anion; Tempol

Indexed keywords

3 INDOLEMETHANOL; ANGIOTENSIN; SODIUM CHLORIDE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; GLOMERULUS FILTRATION RATE; HIGH SODIUM INTAKE; HYPERTENSION; KIDNEY BLOOD FLOW; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 15044354907     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00148.2004     Document Type: Article

References (37)

1. Alvarez-Guerra M and Garay RP. Renal Na-K-Cl cotransporter NKCC2 in Dahl salt-sensitive rats. J Hypertens 20: 721-727, 2002.
2. Atarashi K, Ishiyama A, Takagi M, Minami M, Kimura K, Goto A, and Omata M. Vitamin E ameliorates the renal injury of Dahl salt-sensitive rats. Am J Hypertens 10: 116S-119S, 1997.
3. Bragulat E and de la Sierra A. Salt intake, endothelial dysfunction, and salt-sensitive hypertension. J Clin Hypertens 4: 41-46, 2002.
4. Campbell SJ, Carlotti F, Hall PA, Clark AJ, and Wolf CR. Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation. J Cell Sci. 109: 2619-2625, 1996.
5. Castrop H, Kramer BK, Riegger GA, Kurtz A, and Wolf K. Overexpression of chloride channel CLC-K2 mRNA in the renal medulla of Dahl salt-sensitive rats. J Hypertens 18: 1289-1295, 2000.
6. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, and Wilcox CS. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285: R117-R124, 2003.
7. Forrester LM, Henderson CJ, Glancey MJ, Back DJ, Park BK, Ball SE, Kitteringham NR, McLaren AW, Miles JS, Skett P, and Wolf CR. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J 281: 359-368, 1992.
8. Gelboin HV. Benzo[α]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 60: 1107-1166, 1980.
9. Hoagland KM, Maier KG, and Roman RJ. Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats. Hypertension 41: 697-702, 2003.
10. 1 receptors support arterial pressure in Dahl salt-sensitive rats. Hypertension 41: 744-750, 2003.
11. Jellinck PH, Forkert PG, Riddick DS, Okey AB, Michnovicz JJ, and Bradlow HL. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol 45: 1129-1136, 1993.
12. Kanachuvesiri S, Fleming S, Peters J, Peters B, Brookert G, Lammie A, McGrath I, Kotelevtsev Y, and Mullins J. Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. J Biol Chem 276: 36727-36733, 2001.
13. Lacy F, O'Connor DT, and Schmid-Schonbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. Hypertension 16: 291-303, 1998.
14. Lombardi D, Gordon KL, Polinsky P, Suga S, Schwartz SM, and Johnson RJ. Salt-sensitive hypertension develops after short-term exposure to angiotensin II. Hypertension 33: 1013-1019, 1999.
15. Loub WD, Wattenberg LW, and Davis DW. Aryl hydrocarbon hydroxylase induction in rat tissues by naturally occurring indoles of cruciferous plants. J Natl Cancer Inst 54: 985-988, 1975.
16. Meng S, Cason GW, Gannon AW, Racusen LC, and Manning RD Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 41: 1346-1352, 2003.
17. Meng S, Roberts LJ II, Cason GW, Curry TS, and Manning RD Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol Regul Integr Comp Physiol 283: R732-R738, 2002.
18. Mitchell JB, DeGraff W, Kaufman D, Krishna MC, Samuni A, Finkelstein E, Ahn MS, Hahn SM, Gamson J, and Russo A. Inhibition of oxygen-dependent radiation-induced damage by nitroxide superoxide dismutase mimetic, tempol. Arch Biochem Biophys 289: 62-70, 1991.
19. Mitchell JB, Samuni A, Krishna MC, DeGraff WG, Ahn MS, Samuni U, and Russo A. Biologically active metal-independent superoxide dismutase mimetics. Biochemistry 29: 2802-2807, 1990.
20. Mitchell KD and Mullins JJ. ANG II dependence of tubuloglomerular feedback responsiveness in hypertensive ren-2 transgenic rats. Am J Physiol Renal Fluid Electrolyte Physiol 268: F821-F828, 1995.
21. Pelkonen O and Nebert DW. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol Rev 34: 189-222, 1982.
22. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
23. Rodriguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincon J, Chavez M, Parra G, Herrera-Acosta J, Gomez-Garre D, Largo R, Egido J, and Johnson RJ. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 59: 2222-2232, 2001.
24. Samuni A, Godinger D, Aronovitch J, Russo A, and Mitchell JB. Nitroxides block DNA scission and protect cells from oxidative damage. Biochemistry 30: 555-561, 1991.
25. Samuni A, Krishna CM, Mitchell JB, Collins CR, and Russo A. Superoxide reactions with nitroxides. Free Rad Res Commun 9: 241-249, 1990.
26. Samuni A, Min A, Krishna CM, Mitchell JB, and Russo A. SOD-like activity of 5-membered ring nitroxide spin labels. Adv Exp Med Biol 264: 85-92, 1990.
27. Samuni A, Mitchell JB, DeGraff W, Krshna CM, Samuni U, and Russo A. Nitroxide SOD-mimetics: mode of action. Free Rad Res Commun 12-13: 187-194, 1991.
28. Samuni A, Winkelsberg A, Pinson A, Hahn SM, Mitchell JB, and Russo A. Nitroxide stable radicals protect beating cardiomyocytes against oxidative damage. J Clin Invest 87: 1526-1530, 1991.
29. Schnackenberg C, Welch W, and Wilcox C. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic. Role of nitric oxide. Hypertension 32: 59-64, 1998.
30. 2α. Hypertension 33: 424-428, 1999.
31. Smith JD, Wong E, and Ginsberg M. Cytochrome P450 1A1 promoter as a genetic switch for the regulatable and physiological expression of a plasma protein in transgenic mice. Proc Natl Acad Sci USA 92: 11926-11930, 1995.
32. Swei A, Lacy F, DeLano FA, and Schmid-Schonbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension 30: 1628-1633, 1997.
33. Vaneckova I. Function of the isolated perfused kidney in young and adult spontaneously hypertensive and Dahl salt-sensitive rats. Kidney Blood Press Res 25: 315-321, 2002.
34. Ward RJ, Abiaka C, and Peters TJ. Inflammation and tissue injury: the world of free radicals. J Nephrol 7: 89-95, 1994.
35. Wilcox CS and Welch WJ. Interaction between nitric oxide and oxygen radicals in regulation of tubuloglomerular feedback. Acta Physiol Scand 168: 119-124, 2000.
36. - in DOCA-salt rats. Hypertension 43: 329-334, 2004.
37. Zhao X, Pollock DM, Inscho EW, Zeldin DC, and Imig JD. Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension. Hypertension 41: 709-714, 2003.